Evidence map›Paper›PMID 37186819›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

COVID-19-related hyperglycemia is associated with infection of hepatocytes and stimulation of gluconeogenesis.

Ester A Barreto, Amanda S Cruz, Flavio P Veras, Ronaldo Martins, Rafaella S Bernardelli, Isadora M Paiva, Thais M Lima, Youvika Singh, Raphael C Guimarães, Samara Damasceno and 20 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. SARS-CoV-2 Main Protease Dysregulates Hepatic Insulin Signaling and Glucose Uptake: Implications for Post-COVID-19 Diabetogenesis.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Pathological Sequelae of SARS-CoV-2: A Review for Clinicians.The Yale journal of biology and medicine · 2024
    Review
  18. LongitudinalViruses · 2024
    Article
  19. Interactions of SARS-CoV-2 with Human Target Cells-A Metabolic View.International journal of molecular sciences · 2024
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors at 5 institutions in 1 country.

Ester A BarretoDepartment of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Amanda S CruzDepartment of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.ORCID 0000-0001-6072-1721
Flavio P VerasDepartment of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.ORCID 0000-0002-6222-4064
Ronaldo MartinsDepartment of Cell Biology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.ORCID 0000-0002-8902-5962
Rafaella S BernardelliFederal University of Paraná, Center for Study and Research in Intensive Care Medicine, Curitiba 82530-200, Brazil.
Isadora M PaivaDepartment of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.ORCID 0000-0002-2741-150X
Thais M LimaDepartment of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Youvika SinghHospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.ORCID 0000-0002-4274-4484
Raphael C GuimarãesDepartment of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas, Campinas 13083-970, Brazil.
Samara DamascenoDepartment of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.ORCID 0000-0002-0215-4420
Nayara PereiraDepartment of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
João Manoel AlvesDepartment of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Tiago T GonçalvesDepartment of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.ORCID 0000-0002-7503-6062
Julia ForatoDepartment of Genetics, Microbiology and Immunology, Laboratory of Emerging Viruses, Institute of Biology, University of Campinas, Campinas 13083-970, Brazil.ORCID 0000-0002-6247-9657
Stéfanie P MuraroDepartment of Genetics, Microbiology and Immunology, Laboratory of Emerging Viruses, Institute of Biology, University of Campinas, Campinas 13083-970, Brazil.ORCID 0000-0002-5105-6659
Gabriela F SouzaDepartment of Genetics, Microbiology and Immunology, Laboratory of Emerging Viruses, Institute of Biology, University of Campinas, Campinas 13083-970, Brazil.ORCID 0000-0001-7285-0790
Sabrina Setembre BatahDepartment of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
José L Proenca-ModenaDepartment of Genetics, Microbiology and Immunology, Laboratory of Emerging Viruses, Institute of Biology, University of Campinas, Campinas 13083-970, Brazil.ORCID 0000-0002-4996-3153
Marcelo A MoriDepartment of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas, Campinas 13083-970, Brazil.ORCID 0000-0001-7112-5263
Fernando Q CunhaDepartment of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Paulo Louzada-JuniorCenter for Research in Inflammatory Diseases, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.ORCID 0000-0003-2585-3870
Thiago M CunhaDepartment of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Helder I NakayaCenter for Research in Inflammatory Diseases, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.ORCID 0000-0001-5297-9108
Alexandre FabroDepartment of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Renê D R de OliveiraDivisions of Clinical Immunology, Emergency, Infectious Diseases, and Intensive Care Unit, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Eurico ArrudaDepartment of Cell Biology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.ORCID 0000-0002-0978-410X
Rosângela RéaFederal University of Paraná, Center for Study and Research in Intensive Care Medicine, Curitiba 82530-200, Brazil.
Álvaro Réa NetoFederal University of Paraná, Center for Study and Research in Intensive Care Medicine, Curitiba 82530-200, Brazil.ORCID 0000-0001-5524-0907
Miguel M Fernandes da SilvaHospital de Clínicas da Universidade Federal do Paraná, Curitiba 80060-900, Brazil.
Luiz Osório LeiriaDepartment of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Universidade de São Paulo · BRUniversidade Estadual de Campinas (UNICAMP) · BRHospital de Clínicas Universidade Federal do Paraná · BRHospital Israelita Albert Einstein · BRUniversidade Federal do Paraná · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Occurrence of hyperglycemia upon infection is associated with worse clinical outcome in COVID-19 patients. However, it is still unknown whether SARS-CoV-2 directly triggers hyperglycemia. Herein, we interrogated whether and how SARS-CoV-2 causes hyperglycemia by infecting hepatocytes and increasing glucose production. We performed a retrospective cohort study including patients that were admitted at a hospital with suspicion of COVID-19. Clinical and laboratory data were collected from the chart records and daily blood glucose values were analyzed to test the hypothesis on whether COVID-19 was independently associated with hyperglycemia. Blood glucose was collected from a subgroup of nondiabetic patients to assess pancreatic hormones.

Indexed as

COVID-19HyperglycemiaBlood GlucoseGluconeogenesisGlucoseHepatocytesHumansRetrospective StudiesSARS-CoV-2Blood GlucoseGlucoseglucoseliverSARS-CoV-2

Identifiers

PMID37186819
PMCPMC10214153
OpenAlexW4376603034

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.